Polaris Venture Management Co. V as of Sept. 30, 2020
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 9 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics Common Stock (FATE) | 56.3 | $34M | 855k | 39.97 | |
| Lyra Therapeutics Common Stock (LYRA) | 20.3 | $12M | 1.1M | 11.18 | |
| Selecta Biosciences Common Stock | 11.3 | $6.9M | 2.8M | 2.48 | |
| Neuronetics Common Stock (STIM) | 5.9 | $3.6M | 733k | 4.86 | |
| x4 Pharmaceuticals Common Stock (XFOR) | 3.5 | $2.1M | 312k | 6.77 | |
| Genocea Biosciences Common Stock (GNCAQ) | 0.7 | $452k | 197k | 2.29 | |
| Pulmatrix Common Stock | 0.7 | $428k | 359k | 1.19 | |
| Atyr Pharma Common Stock | 0.7 | $422k | 131k | 3.23 | |
| Dare Bioscience Common Stock | 0.5 | $326k | 326k | 1.00 |
